Nida chaudhry biography of christopher
•
I am an epidemiologist and health informatician with an interdisciplinary background centering on innovative use of routinely collected health data, clinical decision support (CDS), evaluation of health interventions, substance use epidemiology, HIV and aging, and the dynamics between behavioral, social, biological, and environmental factors for disease. My research has taken a multidisciplinary approach to data science with an emphasis on utilizing modern technologies to understand significant human health issues. My early career focused on the intersections between substance use and HIV and HCV, with a strong emphasis on individual, partnership and network-level risk assessment. Following my relocation to the UK, I developed my skills in data science and health informatics, leading to an Alan Turing Fellowship and position as University Lecturer in Clinical Informatics at the University of Cambridge. I established the ethical and computing infrastructure to harness electronic medical data for research from the UK’s first fully integrated electronic health record system for tertiary and acute care (Epic at Cambridge University Hospitals NHS Foundation Trust). From this platform, I developed clinical informatics tools, novel surveillance methods, large research studies, and de
•
All Faculty
- Aadam, A Aziz
- Aaronson, Alexandra L
- Abad, Can D
- Abahuje, Egide
- Abaza, Yasmin
- Abazeed, Mohamed E
- Abbas, Maliha
- Abbasi, Waleed A
- Abbott, Sabra M
- Abboud, Samir F
- Abdala Valencia, Hiam
- Abdalla, Ramez N
- Abdel Mohsen, Mohamed
- Abdulkadir, Sarki A
- Abdulla, Ra-id
- Abdullah, Fizan
- Abihider, Katherine E
- Abraham, Alin K
- Abraham, Anub A
- Abraham, Jeevan C
- Abram, Karen
- Abrego, Fidel
- Achenbach, Chad J
- Achett, George
- Ackermann, Ronald T
- Acosta, Assemblage Maria
- Adam, Hole K
- Adam, Writer A
- Adams, Carmen M
- Adams, Constants R
- Adams, Outlaw G
- Adams, Conventional A
- Adams, Writer L
- Addington, Elizabeth
- Adekola, Kehinde U.A.
- Adeleke, Ibukunoluwa O
- Aderibigbe, Oyinade M
- Adewuyi, Adenike A
- Adhikari, Payal D
- Adler, Mark D
- Adli, Mazhar
- Adney, Thespian K
- Aekka, Apoorva
- Afana, Majed M
- Afifi, Sherif
- Agarwal, Gaurava
- Agarwal, Ghanshyam D
- Agarwal, Shelly
- Agbo, Chinwike T
- Aggarwal, Vikram
- Agins, Erin R
- Agirlar Trabzonlu, Tugce
- Agrawal, Akansha
- Agrawal, Pooja
- Agrawal, Rishi K
- Aguilar, Frank G
- Aguirre, Joseph A
- Agulnek, Abby N
- Ahmad, Faraz S
- Ahmad, Faryal
- Ahmad, Imran N
- Ahmad, Sameen
- Ahmed, Aisha
- Ahmed, Atique U
- Ahmed, Mona
- Ahn, Mary
- Ahn, Yeo Won
- Ahrendsen, Jared T
- Ahuja, Christopher S
- Ahya, Shubhada N
- Ajibewa, Tiwaloluwa
- Ajroud, Kaouther
- Ajr
•
Christopher Grunseich, M.D.
Grunseich C, Miller R, Swan T, Glass DJ, El Mouelhi M, Fornaro M, Petricoul O, Vostiar I, Roubenoff R, Meriggioli MN, Kokkinis A, Guber RD, Budron MS, Vissing J, Soraru G, Mozaffar T, Ludolph A, Kissel JT, Fischbeck KH, BVS857 study group. Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial.Lancet Neurol. 2018;17(12):1043-1052.
Grunseich C, Wang IX, Watts JA, Burdick JT, Guber RD, Zhu Z, Bruzel A, Lanman T, Chen K, Schindler AB, Edwards N, Ray-Chaudhury A, Yao J, Lehky T, Piszczek G, Crain B, Fischbeck KH, Cheung VG. Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters.Mol Cell. 2018;69(3):426-437.e7.
Grunseich C, Patankar A, Amaya J, Watts JA, Li D, Ramirez P, Schindler AB, Fischbeck KH, Cheung VG. Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4.Ann Neurol. 2020;87(4):547-555.
Diarra S, Ghosh S, Cissé L, Coulibaly T, Yalcouyé A, Harmison G, Diallo S, Diallo SH, Coulibaly O, Schindler A, Cissé CAK, Maiga AB, Bamba S, Samassekou O, Khokha MK, Mis EK, Lakhani SA, Donovan FX, Jacobson S, Blackstone C, Guinto CO, Landouré G, Bonifacino JS